AAAAAA
Results:
1-13
|
Results: 13
Authors:
Daniele, B
Secondulfo, M
De Vivo, R
Pignata, S
De Magistris, L
Delrio, P
Palaia, R
Barletta, E
Tambaro, R
Carratu, R
Citation: B. Daniele et al., Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer, J CLIN GAST, 32(3), 2001, pp. 228-230
Authors:
Dragomir, S
Barletta, E
Citation: S. Dragomir et E. Barletta, A new upper bound on the Cheeger number of a graph, J COMB TH B, 82(2), 2001, pp. 167-174
Authors:
Fibbi, G
Barletta, E
Dini, G
Del Rosso, A
Pucci, M
Cerletti, M
Del Rosso, M
Citation: G. Fibbi et al., Cell invasion is affected by differential expression of the urokinase plasminogen activated/urokinase plasminogen activator receptor system in musclesatellite cells from normal and dystrophic patients, LAB INV, 81(1), 2001, pp. 27-39
Authors:
Daniele, B
Perrone, F
Gallo, C
Pignata, S
De Martino, S
De Vivo, R
Barletta, E
Tambaro, R
Abbiati, R
D'Agostino, L
Citation: B. Daniele et al., Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial, GUT, 48(1), 2001, pp. 28-33
Authors:
Gridelli, C
Manzione, L
Perrone, F
Veltri, E
Cioffi, R
Caprio, MG
Frontini, L
Rossi, A
Barletta, E
Barzelloni, ML
Bilancia, D
Gallo, C
Citation: C. Gridelli et al., Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study, BR J CANC, 84(1), 2001, pp. 38-41
Authors:
Mannori, G
Barletta, E
Mugnai, G
Ruggieri, S
Citation: G. Mannori et al., Interaction of tumor cells with vascular endothelia: Role of platelet-activating factor, CLIN EXP M, 18(1), 2000, pp. 89-96
Authors:
Illiano, A
Barletta, E
De Marino, V
Battiloro, C
Barzelloni, M
Scognamiglio, F
Rossi, N
Zampa, G
De Bellis, M
Gridelli, C
Citation: A. Illiano et al., New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study, ANTICANC R, 20(5C), 2000, pp. 3999-4003
Authors:
Gridelli, C
Frontini, L
Barletta, E
Rossi, A
Barzelloni, ML
Scognamiglio, F
Guida, C
Gatani, T
Fiore, F
De Bellis, M
Marfella, A
Manzione, L
Citation: C. Gridelli et al., Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature, ANTICANC R, 20(2B), 2000, pp. 1077-1084
Authors:
Gridelli, C
Guida, C
Barletta, E
Gatani, T
Fiore, F
Barzelloni, ML
Rossi, A
de Bellis, M
D'Aniello, R
Scognamiglio, F
Citation: C. Gridelli et al., Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study, LUNG CANC, 29(2), 2000, pp. 131-137
Authors:
Gridelli, C
Cigolari, S
Maiorino, A
Ianniello, GP
Brancaccio, L
Rossi, A
De Cataldis, G
Pedicini, T
Maiorino, L
Barletta, E
Di Lanno, M
Bilancia, D
Crispino, C
Barzelloni, ML
Masullo, P
D'Aniello, R
Manzione, L
Citation: C. Gridelli et al., Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study, LUNG CANC, 28(3), 2000, pp. 237-244
Authors:
Ruggieri, S
Mugnai, G
Mannini, A
Calorini, L
Fallani, A
Barletta, E
Mannori, G
Cecconi, O
Citation: S. Ruggieri et al., Lipid characteristics in metastatic cells, CLIN EXP M, 17(4), 1999, pp. 271-276
Authors:
Gridelli, C
Perrone, F
Gallo, C
Rossi, A
Barletta, E
Barzelloni, ML
Creazzola, S
Gatani, T
Fiore, F
Guida, C
Scognamiglio, F
Citation: C. Gridelli et al., Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial, ANTICANC R, 19(5C), 1999, pp. 4535-4538
Authors:
Barletta, E
Dragomir, S
Citation: E. Barletta et S. Dragomir, On transversally holomorphic maps of Kahlerian foliations, ACT APPL MA, 54(2), 1998, pp. 121-134
Risultati:
1-13
|